Trendlines raises $3.2m fund for distribution of new surgical instrument

The new instrument will be used for abdominal operations.

Singapore-listed medical investor The Trendlines Group has won a $3.2m funding to start marketing and distributing a new surgical instrument that will be used in abdominal operations.

The funding is directed to Trendlines' medical portfolio company Gordian Surgical, which developed TroClose1200. Gordian announced that it has already secured Food and Drug Administration regulatory clearance for the new instrument.

The development is to give surgeons “two-in-one” functionality: the device acts both as a trocar, through which surgical instruments enter the abdomen, and a device to close internal incisions made during surgery.

“Receiving FDA clearance is a huge milestone in Gordian’s strategic roadmap. The recent investment, led by B. Braun, allows us to move rapidly towards commercialization of our device in the U.S., Europe and other markets," Gordian Surgical CEO Zvi Pe’er said.

If you've been wondering whether SBR could work for your company — yes, probably.

A lot of the companies we partner with started as readers. They'd been following our coverage for a while, saw their own customers and competitors in it, and eventually asked the obvious question: could we do something with you? The answer is usually yes. The shape of it depends on what you're trying to do.

The options are broader than most people assume — thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. Some partners use one channel; most use a mix. We figure out the right combination by starting with your brief, not with our rate card.

So if the question has been on your mind, here's the easy way to ask it.

We'll tell you honestly whether we can help, and how. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia